Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$78.05M+2.9%$75.85M+11.5%$68.03M+10.9%$61.37M+11.7%$54.96M+14.6%
$29.36M+32.3%$22.18M-3.4%$22.96M+9.0%$21.07M-8.7%$23.06M+45.6%
$48.69M-9.3%$53.66M+19.1%$45.07M+11.8%$40.31M+26.4%$31.9M-0.7%
62.4%-8.4pp70.8%+4.5pp66.3%+0.6pp65.7%+7.6pp58%-8.9pp
$12.7M+9.9%$11.55M+12.1%$10.3M+2.8%$10.02M+13.8%$8.81M-4.2%
$26.79M+8.8%$24.61M+7.3%$22.94M+2.8%$22.32M+10.6%$20.17M+11.5%
$13.99M-1.6%$14.22M-0.9%$14.34M+16.5%$12.31M+8.7%$11.32M-5.3%
$53.47M+6.1%$50.38M+5.9%$47.58M+6.6%$44.65M+10.8%$40.3M+2.7%
-$4.78M-$2.51M+42.2%-$4.34M+48.3%-$8.4M-18.3%
-6.1%-3.7%+3.4pp-7.1%+8.2pp-15.3%-0.5pp
$18K+38.5%$13K-96.3%$353K-67.7%$1.09M+1.9%$1.07M-2.1%
$1.81M-$665K+31.2%-$967K+8.1%-$1.05M+8.5%
-$2.97M-$3.18M+40.2%-$5.31M+43.8%-$9.45M-14.5%
$0$0$0$0$0
-$2.97M-$3.18M+40.2%-$5.31M+43.8%-$9.45M-14.5%
-3.8%-4.7%+4.0pp-8.7%+8.5pp-17.2%0.0pp
-$0.05-$0.06+75.0%-$0.24+79.1%-$1.15-12.7%
-$3.27M-$1.15M+61.4%-$2.99M+57.6%-$7.06M-21.3%
-4.2%-1.7%+3.2pp-4.9%+8.0pp-12.9%-0.7pp
-$4.78M-$2.51M+42.2%-$4.34M+48.3%-$8.4M-18.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Omada Health, Inc. Common Stock's revenue?
Omada Health, Inc. Common Stock (OMDA) generated $283.3M in revenue over the trailing twelve months, up 49.4% year over year.
Is Omada Health, Inc. Common Stock profitable?
Omada Health, Inc. Common Stock is not currently profitable: it reported a net loss of $20.9M over the trailing twelve months, a -11.3% net margin.
What are Omada Health, Inc. Common Stock's profit margins?
Gross margin is 66.3% and operating margin is -9.6%, with a -11.3% net margin.
What is Omada Health, Inc. Common Stock's earnings per share?
Omada Health, Inc. Common Stock's diluted EPS over the trailing twelve months is $-1.50.
Where does Omada Health, Inc. Common Stock's income statement data come from?
Every line is extracted from Omada Health, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.